BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36253360)

  • 1. A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma.
    Zhou RW; Xu J; Martin TC; Zachem AL; He J; Ozturk S; Demircioglu D; Bansal A; Trotta AP; Giotti B; Gryder B; Shen Y; Wu X; Carcamo S; Bosch K; Hopkins B; Tsankov A; Steinhagen R; Jones DR; Asara J; Chipuk JE; Brody R; Itzkowitz S; Chio IIC; Hasson D; Bernstein E; Parsons RE
    Nat Commun; 2022 Oct; 13(1):6041. PubMed ID: 36253360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.
    Cohen AJ; Saiakhova A; Corradin O; Luppino JM; Lovrenert K; Bartels CF; Morrow JJ; Mack SC; Dhillon G; Beard L; Myeroff L; Kalady MF; Willis J; Bradner JE; Keri RA; Berger NA; Pruett-Miller SM; Markowitz SD; Scacheri PC
    Nat Commun; 2017 Feb; 8():14400. PubMed ID: 28169291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
    Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
    Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology of super-enhancer reprogramming and activation in cancer.
    Zhou RW; Parsons RE
    Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant activation of CYR61 enhancers in colorectal cancer development.
    Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
    J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.
    Chen H; Zheng J; Yan L; Zhou X; Jiang P; Yan F
    J Clin Lab Anal; 2021 Jun; 35(6):e23780. PubMed ID: 33942366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastin is a key factor of tumor development in colorectal cancer.
    Li J; Xu X; Jiang Y; Hansbro NG; Hansbro PM; Xu J; Liu G
    BMC Cancer; 2020 Mar; 20(1):217. PubMed ID: 32171282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer.
    Yu D; Yang X; Lin J; Cao Z; Lu C; Yang Z; Zheng M; Pan R; Cai W
    Front Oncol; 2021; 11():724655. PubMed ID: 34336707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
    Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
    Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK12 orchestrates super-enhancer-associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer.
    Dai W; Wu J; Peng X; Hou W; Huang H; Cheng Q; Liu Z; Luyten W; Schoofs L; Zhou J; Liu S
    Clin Transl Med; 2022 Oct; 12(10):e1087. PubMed ID: 36254394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity.
    Long X; Wong CC; Tong L; Chu ESH; Ho Szeto C; Go MYY; Coker OO; Chan AWH; Chan FKL; Sung JJY; Yu J
    Nat Microbiol; 2019 Dec; 4(12):2319-2330. PubMed ID: 31501538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Lu J; Zhang L; Zhou H; Du Z; Zhang G
    Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of enhancer-driven S100A14 expression promotes esophageal carcinogenesis.
    Li X; Ding F; Wang L; Chen H; Liu Z
    Cancer Lett; 2022 Oct; 545():215833. PubMed ID: 35917972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1.
    Ying Y; Wang Y; Huang X; Sun Y; Zhang J; Li M; Zeng J; Wang M; Xiao W; Zhong L; Xu B; Li L; Tao Q; Wang X; Shu XS
    Oncogene; 2020 Jan; 39(5):1004-1017. PubMed ID: 31591481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
    Liang X; Duronio GN; Yang Y; Bala P; Hebbar P; Spisak S; Sahgal P; Singh H; Zhang Y; Xie Y; Cejas P; Long HW; Bass AJ; Sethi NS
    Gastroenterology; 2022 Jan; 162(1):209-222. PubMed ID: 34571027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
    Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
    Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.